DSGN

Design TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

RSI (14)

54.0

Neutral

MACD Hist

-0.11

Bearish

ATR (14)

0.65

Normal

Vol Z (20)

1.13

Normal

RET 20D

+2.5%

Positive

Dist 52W High

-5.8%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-09-09

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Uptrend (SMA20 > SMA50 > SMA200)

Momentum

Positive momentum · 20D +2.5% · 60D +34.8%

RSI / MACD

RSI 54.0 (Neutral) · MACD hist -0.11

Volatility

Volatility elevated (Z 1.13)

SMA20

15.19

SMA50

14.12

SMA200

11.72

EMA12

15.13

EMA26

14.77

BB Upper

15.88

BB Mid

15.19

BB Lower

14.50

RET 5D

-3.3%

RET 20D

+2.5%

RET 60D

+34.8%

RET 120D

+46.4%

As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data